Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PGE1 accelerates thrombolysis by tissue plasminogen activator.

D E Vaughan1, S R Plavin, A I Schafer

  • 1Division of Cardiology, Brigham and Women's Hospital, Boston, MA.

Blood
|April 1, 1989
PubMed
Summary

Prostaglandin E1 significantly speeds up clot dissolution during thrombolytic therapy. This antiplatelet agent enhances thrombolysis rates, suggesting its utility in improving treatment outcomes for thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.

Clinical pharmacology and therapeutics·2019
Same author

Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Developing new drug treatments in the era of network medicine.

Clinical pharmacology and therapeutics·2012
Same author

Detection of nitrosated proteins.

Current protocols in toxicology·2012
Same author

The effect of intermittent operation on a wind-powered membrane system for brackish water desalination.

Water science and technology : a journal of the International Association on Water Pollution Research·2012
Same author

Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.

Amino acids·2011

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Pharmacology

Background:

  • Platelets are crucial in thrombus formation and can impact thrombolysis rates.
  • Plasminogen activators are key in dissolving blood clots.

Purpose of the Study:

  • To evaluate the role of platelet aggregation in thrombolytic response.
  • To assess the effect of prostaglandin E1 on tissue plasminogen activator-induced thrombolysis.

Main Methods:

  • A rabbit jugular vein thrombosis model was utilized.
  • Rates of thrombolysis were measured with and without prostaglandin E1 coinfusion.
  • Thrombus lysis half-time was quantified.

Main Results:

  • Prostaglandin E1 significantly reduced clot lysis half-time across all tissue plasminogen activator concentrations.

Related Experiment Videos

  • Enhanced thrombolysis extent was observed with prostaglandin E1.
  • Platelet inhibition was evidenced ex vivo, without significant changes in fibrinogen or mean arterial pressure.

    • Conclusions:

    • Antiplatelet prostaglandin E1 improves the rate of thrombolysis.
    • Prostaglandin E1 shows potential as an adjunctive agent in thrombolytic therapy.
    • Enhanced thrombolytic efficacy is linked to platelet inhibition.